How Type 2 Diabetes Can Weaken the Immune System Against Cancer
Share
Introduction
Type 2 diabetes (T2D) and cancer are two of the most common chronic diseases worldwide. Many people suffer from both, and scientists are beginning to understand how these conditions interact. A recent review highlights how diabetes doesn’t just affect blood sugar—it also changes how the immune system responds to cancer, making it harder for the body to fight tumors.
The Link Between Diabetes and Cancer
It’s well known that people with T2D are at higher risk for developing several types of cancer, including breast, colon, and pancreatic cancers. But it’s not just a coincidence. Diabetes causes high blood sugar (hyperglycemia) and high insulin levels (hyperinsulinemia), both of which can fuel tumor growth. Beyond that, diabetes changes how immune cells work—especially in the tumor environment.
How Diabetes Affects Immune Cells in Tumors
In a healthy person, immune cells like macrophages, T cells, and natural killer (NK) cells help detect and destroy cancer cells. In people with diabetes, these immune cells often become less effective. For example:
- Macrophages, which usually attack harmful cells, become more “tolerant” and support tumor growth instead.
- Dendritic cells, responsible for alerting other immune cells to threats, don’t work as well in high-sugar environments.
- CD8+ T cells, which are the body's primary tumor-killers, become tired and less able to destroy cancer cells.
- NK cells, another cancer-fighting cell type, are fewer in number and less active in diabetic patients.
Diabetes Makes Tumors More Difficult to Treat
These changes mean that tumors in diabetic people can grow faster and resist treatments like immunotherapy, which relies on a strong immune response. In mouse studies, tumors in diabetic animals were larger and had more immune-suppressing cells than those in non-diabetic mice. These effects have also been observed in human studies, especially in people with pancreatic and colorectal cancers.
Can Diabetes Medications Help?
Interestingly, some diabetes treatments may improve the immune system’s response to cancer. For instance, metformin, a common diabetes drug, has been shown to reduce tumor size, improve immune cell activity, and even make cancer treatments more effective. SGLT2 inhibitors and insulin have also shown promise in reversing some of the immune problems caused by diabetes.
What This Means for Patients
If you have both diabetes and cancer, your body may struggle more to fight tumors. But this doesn’t mean you’re helpless. Managing your blood sugar and using diabetes medications that support immune health can help. Doctors may also need to adjust cancer treatments to better suit people with diabetes, especially when using immunotherapy.
Conclusion
Type 2 diabetes doesn’t just affect blood sugar—it can also make it harder for the immune system to fight cancer. Researchers are still learning about these effects, but what’s clear is that managing diabetes carefully may improve cancer outcomes. Combining the right treatments for both conditions could offer better protection and hope for patients.